Skip to main content

Table 3 Variation of FEV1 during follow up

From: A pilot trial on safety and efficacy of erythrocyte-mediated steroid treatment in CF patients

  Erythrocyte mediated steroid therapy Ordinary therapy P value
FEV1 at enrolment (-12 months), average (95% CI) 53.8 (25.6–82.0) 56.8 (30.0–83.6) 0.68
FEV1 at time +12, average (95% CI) 56.7 (23.8–89.6) 55.1 (26.5–83.7) 0.83
FEV1 at time +24, average (95% CI) 59.8 (22.4–97.2) 53.2 (21.7–84.7) 0.48